A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Clinical trial NCT05490446 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05490446
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-07
- Primary completion
- 2026-03-17
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.